date:Aug 22, 2012
But the company remained upbeat with deals blossoming under its new licensing arrangement for some of its probiotic strains with Nestl.
Net sales for the half fell 3% to 18.63m, excluding the 50.8m Nestl licensing deal signed in Q1.
Earlier this year, as previously mentioned, we signed several agreements with Nestl through which they have among other things obtained exclusive rights to useLactobacillus reuteriin infant formula throughout the term of patent in order to guarantee their access to